1. Casilli, G, Lidonnici, D, Jommi, C, De Nigris, M, Genazzani, AA. Do France, Germany, and Italy agree on the added therapeutic value of medicines?. Int J Technol Assess Health Care. 2023;39 (1):e54. doi: 10.1017/S026646232300048X. PubMed PMID:37580971 .
  2. Lim, D, Tapella, L, Dematteis, G, Genazzani, AA, Corazzari, M, Verkhratsky, A et al.. The endoplasmic reticulum stress and unfolded protein response in Alzheimer's disease: A calcium dyshomeostasis perspective. Ageing Res Rev. 2023;87 :101914. doi: 10.1016/j.arr.2023.101914. PubMed PMID:36948230 .
  3. Dionisi, M, Riva, B, Delconti, M, Meregalli, C, Chiorazzi, A, Canta, A et al.. Inhibition of NHE1 transport activity and gene transcription in DRG neurons in oxaliplatin-induced painful peripheral neurotoxicity. Sci Rep. 2023;13 (1):3991. doi: 10.1038/s41598-023-31095-9. PubMed PMID:36894669 PubMed Central PMC9998445.
  4. Colombo, G, Caviglia, GP, Ravera, A, Tribocco, E, Frara, S, Rosso, C et al.. NAMPT and NAPRT serum levels predict response to anti-TNF therapy in inflammatory bowel disease. Front Med (Lausanne). 2023;10 :1116862. doi: 10.3389/fmed.2023.1116862. PubMed PMID:36817780 PubMed Central PMC9928959.
  5. Tapella, L, Dematteis, G, Genazzani, AA, De Paola, M, Lim, D. Immortalized hippocampal astrocytes from 3xTg-AD mice, a new model to study disease-related astrocytic dysfunction: a comparative review. Neural Regen Res. 2023;18 (8):1672-1678. doi: 10.4103/1673-5374.363192. PubMed PMID:36751778 PubMed Central PMC10154476.
  6. Gong, C, Bonfili, L, Zheng, Y, Cecarini, V, Cuccioloni, M, Angeletti, M et al.. Immortalized Alzheimer's Disease Astrocytes: Characterization of Their Proteolytic Systems. Mol Neurobiol. 2023;60 (5):2787-2800. doi: 10.1007/s12035-023-03231-z. PubMed PMID:36729287 PubMed Central PMC10039838.
  7. Armandi, A, Colombo, G, Rosso, C, Caviglia, GP, Olivero, A, Abate, ML et al.. The Predictive Role of Extracellular NAPRT for the Detection of Advanced Fibrosis in Biopsy-Proven Non-Alcoholic Fatty Liver Disease. Int J Mol Sci. 2023;24 (2):. doi: 10.3390/ijms24021172. PubMed PMID:36674688 PubMed Central PMC9861383.
  8. Foroutan, A, Corazzari, M, Grolla, AA, Colombo, G, Travelli, C, Genazzani, AA et al.. Identification of novel aza-analogs of TN-16 as disrupters of microtubule dynamics through a multicomponent reaction. Eur J Med Chem. 2023;245 (Pt 1):114895. doi: 10.1016/j.ejmech.2022.114895. PubMed PMID:36370553 .
  9. Tapella, L, Dematteis, G, Moro, M, Pistolato, B, Tonelli, E, Vanella, VV et al.. Protein synthesis inhibition and loss of homeostatic functions in astrocytes from an Alzheimer's disease mouse model: a role for ER-mitochondria interaction. Cell Death Dis. 2022;13 (10):878. doi: 10.1038/s41419-022-05324-4. PubMed PMID:36257957 PubMed Central PMC9579125.
  10. Lim, D, Tapella, L, Dematteis, G, Talmon, M, Genazzani, AA. Calcineurin Signalling in Astrocytes: From Pathology to Physiology and Control of Neuronal Functions. Neurochem Res. 2023;48 (4):1077-1090. doi: 10.1007/s11064-022-03744-4. PubMed PMID:36083398 PubMed Central PMC10030417.
  11. Trapani, D, Tay-Teo, K, Tesch, ME, Roitberg, F, Sengar, M, Altuna, SC et al.. Implications of Oncology Trial Design and Uncertainties in Efficacy-Safety Data on Health Technology Assessments. Curr Oncol. 2022;29 (8):5774-5791. doi: 10.3390/curroncol29080455. PubMed PMID:36005193 PubMed Central PMC9406873.
  12. Costa, E, Grimaldi, G, Del Grosso, V, Isgrò, A, Genazzani, A. [Access to medicines for rare diseases: regulatory aspects and public health priorities.]. Recenti Prog Med. 2022;113 (7):415-424. doi: 10.1701/3850.38335. PubMed PMID:35852076 .
  13. Imperio, D, Grolla, AA, Moro, M, Bortolotto, V, Del Grosso, E, Genazzani, AA et al.. Functionalization of β-cyclodextrin with a urea-based PSMA ligand and preliminary studies on targeting prostate cancer cells. Bioorg Med Chem Lett. 2022;73 :128890. doi: 10.1016/j.bmcl.2022.128890. PubMed PMID:35839965 .
  14. Galai, E, Scotti, L, Gilardetti, M, Ucciero, A, Ferrante, D, Poluzzi, E et al.. Time-Trends of Drug-Drug Interactions among Elderly Outpatients in the Piedmont Region (Italy): A Population-Based Study. Int J Environ Res Public Health. 2022;19 (12):. doi: 10.3390/ijerph19127353. PubMed PMID:35742605 PubMed Central PMC9224286.
  15. Cordero-Sanchez, C, Pessolano, E, Riva, B, Vismara, M, Trivigno, SMG, Clemente, N et al.. CIC-39Na reverses the thrombocytopenia that characterizes tubular aggregate myopathy. Blood Adv. 2022;6 (15):4471-4484. doi: 10.1182/bloodadvances.2021006378. PubMed PMID:35696753 PubMed Central PMC9636319.
  16. Riva, B, Pessolano, E, Quaglia, E, Cordero-Sanchez, C, Bhela, IP, Topf, A et al.. STIM1 and ORAI1 mutations leading to tubular aggregate myopathies are sensitive to the Store-operated Ca2+-entry modulators CIC-37 and CIC-39. Cell Calcium. 2022;105 :102605. doi: 10.1016/j.ceca.2022.102605. PubMed PMID:35636153 .
  17. Colombo, G, Travelli, C, Porta, C, Genazzani, AA. Extracellular nicotinamide phosphoribosyltransferase boosts IFNγ-induced macrophage polarization independently of TLR4. iScience. 2022;25 (4):104147. doi: 10.1016/j.isci.2022.104147. PubMed PMID:35402885 PubMed Central PMC8990213.
  18. Villa, F, Di Filippo, A, Pierantozzi, A, Genazzani, A, Addis, A, Trifirò, G et al.. Orphan Drug Prices and Epidemiology of Rare Diseases: A Cross-Sectional Study in Italy in the Years 2014-2019. Front Med (Lausanne). 2022;9 :820757. doi: 10.3389/fmed.2022.820757. PubMed PMID:35252257 PubMed Central PMC8891228.
  19. Dematteis, G, Restelli, E, Vanella, VV, Manfredi, M, Marengo, E, Corazzari, M et al.. Calcineurin Controls Cellular Prion Protein Expression in Mouse Astrocytes. Cells. 2022;11 (4):. doi: 10.3390/cells11040609. PubMed PMID:35203261 PubMed Central PMC8870693.
  20. Antona, A, Varalda, M, Roy, K, Favero, F, Mazzucco, E, Zuccalà, M et al.. Dissecting the Mechanism of Action of Spiperone-A Candidate for Drug Repurposing for Colorectal Cancer. Cancers (Basel). 2022;14 (3):. doi: 10.3390/cancers14030776. PubMed PMID:35159043 PubMed Central PMC8834219.
Search PubMed